Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1557484A H5N1 Booster in Adults
NCT00771615Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2008
- Primary completion
- May 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 2, randomised, single-blind trial of influenza A (Q-Pan H5N1) virus monovalent vaccine (A/Indonesia) in Avian Influenza (AI) (9 arms), sponsored by GSK. Primary endpoints: Number of Seroconverted Subjects for Haemagglutination Inhibition (HI) Antibodies at Day 10, Number of Subjects Seroprotected for Haemagglutination Inhibition (HI) Antibodies at Day 10 and 1 more. Started Oct 2008; status: completed.
02
Drugs
influenza A (Q-Pan H5N1) virus monovalent vaccine (A/Indonesia)
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on NCT00771615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771615.